News

Press Releases

November 9, 2016Xagenic Announces Successful Testing of Beta X1 System  November 12, 2015Xagenic to Participate in the 2015 Canaccord Genuity
Medical Technologies & Diagnostics Forum 
August 25, 2015Xagenic Appoints Seasoned Industry Veteran Randall Wilhoite
As Vice President of Operations 
July 9, 2015Xagenic Announces $15 Million Financing  June 1, 2015Xagenic Fuels Platform Expansion Strategy with Exclusive
Technology Acquisition 
February 23, 2015Xagenic Honored as the 2015 Life Science Company of the Year
by Life Sciences Ontario 
February 9, 2015Xagenic Hosts CLIA Waiver Panel Discussion at the Molecular Med
Tri-Con 2015 
October 16, 2014Xagenic Appoints Timothy I. Still as President & Chief Executive Officer  October 15, 2014Xagenic Announces $6 Million Genome Canada Funded Project in Partnership with University of Toronto  July 14, 2014Xagenic Announces Second Closing of $25.5M
Series B Financing 
December 2, 2013Xagenic Inc. Completes $20 Million Series B Financing
Funding will Support Product Development and FDA Submission of Testing Platform and First Diagnostic Assay  
February 19, 2013Xagenic Inc. Receives $990,000 From FedDev Ontario's Investing in Business Innovation Initiative
Funding to accelerate the development of a new, rapid molecular diagnostic testing system 
September 11, 2012Xagenic Inc. Appoints Two New Members to Board of Directors
Bruce Cohen appointed Executive Chairman and Erik Holmlin joins Board of Directors  
January 30, 2012Xagenic Inc. Closes $10 Million Series A Financing
Funding will support development of on-demand molecular diagnostic system and lead tests; changes to Board of Directors announced 


In the Media

April 19, 2016Xagenic readies X1 molecular diagnostic beta trials  May 25, 2015Medical Laboratory Observer: CLIA-waived Molecular Diagnostic Tests are Poised to Transform Clinical Microbiology  April 24, 2015American Laboratory: A Molecular Diagnostic Platform for Use in the Physician's Office to Treat Infectious Disease  February 11, 2015Start-Ups Profile: Xagenic Inc., Detecting Nucleic Acids with Electrochemical Sensors  December 8, 2014Xagenic named the 2015 Life Sciences Company of the Year by Life Sciences Ontario (LSO)  September 23, 2014Shana Kelley, Xagenic's CTO, named one of Top 12 Canadian Innovators (Globe & Mail)   September 13, 2014BBC World Service - Shana Kelley, Xagenic CTO, discusses
application of nanotechnology to rapid, cost-effective disease diagnosis on The Forum.  
June 2, 2014Xagenic listed as notable up-and-comer in GEN article "Top 14 Molecular Diagnostics Firms"   May 20, 2014The Globe and Mail: A quicker way of diagnosing diseases   May 20, 2014Xagenic receives Frost & Sullivan 2014 New Product Innovation Leadership Award for Point-of-Care Diagnostics (F&S Best Practices Research report)  November 26, 2012Xagenic Makes the List in "The Few and the Proud: The Biotech Startup Class of 2012"  January 30, 2012MDx Startup Xagenic Closes on $10M Series A Financing Round (free GenomeWeb subscription required)  January 26, 2012Xagenic technology featured on CBC News (see clip starting at 9:49)